Sequence-based design of alpha/beta-peptide foldamers that mimic BH3 domains.
作者信息
Horne W Seth, Boersma Melissa D, Windsor Matthew A, Gellman Samuel H
机构信息
Department of Chemistry, University of Wisconsin, 1101 University Ave., Madison, WI 53706, USA.
出版信息
Angew Chem Int Ed Engl. 2008;47(15):2853-6. doi: 10.1002/anie.200705315.
Abstract
摘要
相似文献
1
Sequence-based design of alpha/beta-peptide foldamers that mimic BH3 domains.
Angew Chem Int Ed Engl. 2008;47(15):2853-6. doi: 10.1002/anie.200705315.
2
Two-face, two-turn α-helix mimetics based on a cross-acridine scaffold: analogues of the Bim BH3 domain.
Chembiochem. 2014 Jun 16;15(9):1280-5. doi: 10.1002/cbic.201402040. Epub 2014 May 18.
3
Design and application of an alpha-helix-mimetic scaffold based on an oligoamide-foldamer strategy: antagonism of the Bak BH3/Bcl-xL complex.
Angew Chem Int Ed Engl. 2003 Feb 3;42(5):535-9. doi: 10.1002/anie.200390154.
4
Helix-loop-helix peptide foldamers and their use in the construction of hydrolase mimetics.
Bioorg Chem. 2018 Dec;81:356-361. doi: 10.1016/j.bioorg.2018.07.012. Epub 2018 Jul 17.
5
Role of single disulfide linkages in the folding and activity of scyllatoxin-based BH3 domain mimetics.
J Pept Sci. 2017 May;23(5):367-373. doi: 10.1002/psc.2999. Epub 2017 Mar 22.
6
Targeting anti-apoptotic Bcl2 proteins with scyllatoxin-based BH3 domain mimetics.
Org Biomol Chem. 2016 Jan 14;14(2):440-446. doi: 10.1039/c5ob02080h.
7
Photoreactive stapled BH3 peptides to dissect the BCL-2 family interactome.
Chem Biol. 2010 Dec 22;17(12):1325-33. doi: 10.1016/j.chembiol.2010.09.015.
8
(alpha/beta+alpha)-peptide antagonists of BH3 domain/Bcl-x(L) recognition: toward general strategies for foldamer-based inhibition of protein-protein interactions.
J Am Chem Soc. 2007 Jan 10;129(1):139-54. doi: 10.1021/ja0662523.
9
Synthesis of conformationally constrained benzoylureas as BH3-mimetics.
Org Biomol Chem. 2012 Jul 21;10(27):5230-7. doi: 10.1039/c2ob25618e. Epub 2012 May 30.
10
Sequence and helicity requirements for the proapoptotic activity of Bax BH3 peptides.
Mol Cancer Ther. 2004 Nov;3(11):1343-54.
引用本文的文献
1
Machine learning-driven discovery of highly selective antifungal peptides containing non-canonical β-amino acids.
Chem Sci. 2025 Feb 20;16(13):5579-5594. doi: 10.1039/d4sc06689h. eCollection 2025 Mar 26.
2
Tackling Undruggable Targets with Designer Peptidomimetics and Synthetic Biologics.
Chem Rev. 2024 Nov 27;124(22):13020-13093. doi: 10.1021/acs.chemrev.4c00423. Epub 2024 Nov 14.
3
Differential membrane binding of α/β-peptide foldamers: implications for cellular delivery and mitochondrial targeting.
Aust J Chem. 2023 Aug;76(8):482-492. doi: 10.1071/ch23063. Epub 2023 Jun 14.
4
Structure-Activity Relationship Studies of Substitutions of Cationic Amino Acid Residues on Antimicrobial Peptides.
Antibiotics (Basel). 2022 Dec 23;12(1):19. doi: 10.3390/antibiotics12010019.
5
Structural Details of BH3 Motifs and BH3-Mediated Interactions: an Updated Perspective.
Front Mol Biosci. 2022 May 24;9:864874. doi: 10.3389/fmolb.2022.864874. eCollection 2022.
6
Controlling the conformational stability of coiled-coil peptides with a single stereogenic center of a peripheral β-amino acid residue.
RSC Adv. 2022 Feb 7;12(8):4640-4647. doi: 10.1039/d2ra00111j. eCollection 2022 Feb 3.
7
Harnessing the Therapeutic Potential of Biomacromolecules through Intracellular Delivery of Nucleic Acids, Peptides, and Proteins.
Adv Healthc Mater. 2022 Jun;11(12):e2102600. doi: 10.1002/adhm.202102600. Epub 2022 Mar 23.
8
Prerequisites for Stabilizing Long-Range Synergistic Interactions among -, -, and -Residues in Coiled Coils.
Biochemistry. 2022 Mar 1;61(5):319-326. doi: 10.1021/acs.biochem.1c00760. Epub 2022 Feb 7.
9
Spontaneous transmembrane pore formation by short-chain synthetic peptide.
Biophys J. 2021 Oct 19;120(20):4557-4574. doi: 10.1016/j.bpj.2021.08.033. Epub 2021 Sep 1.
10
Computational Modeling as a Tool to Investigate PPI: From Drug Design to Tissue Engineering.
Front Mol Biosci. 2021 May 20;8:681617. doi: 10.3389/fmolb.2021.681617. eCollection 2021.
本文引用的文献
1
Exploration of backbone space in foldamers containing alpha- and beta-amino acid residues: developing protease-resistant oligomers that bind tightly to the BH3-recognition cleft of Bcl-xL.
Chembiochem. 2007 May 25;8(8):903-16. doi: 10.1002/cbic.200600546.
2
Foldamers as versatile frameworks for the design and evolution of function.
Nat Chem Biol. 2007 May;3(5):252-62. doi: 10.1038/nchembio876.
3
Structural insights into the degradation of Mcl-1 induced by BH3 domains.
Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6217-22. doi: 10.1073/pnas.0701297104. Epub 2007 Mar 27.
4
Helix bundle quaternary structure from alpha/beta-peptide foldamers.
J Am Chem Soc. 2007 Apr 11;129(14):4178-80. doi: 10.1021/ja070396f. Epub 2007 Mar 16.
5
The Bcl-2 apoptotic switch in cancer development and therapy.
Oncogene. 2007 Feb 26;26(9):1324-37. doi: 10.1038/sj.onc.1210220.
6
(alpha/beta+alpha)-peptide antagonists of BH3 domain/Bcl-x(L) recognition: toward general strategies for foldamer-based inhibition of protein-protein interactions.
J Am Chem Soc. 2007 Jan 10;129(1):139-54. doi: 10.1021/ja0662523.
7
Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members.
Cancer Cell. 2006 May;9(5):351-65. doi: 10.1016/j.ccr.2006.03.027.
8
Rational development of beta-peptide inhibitors of human cytomegalovirus entry.
J Biol Chem. 2006 Feb 3;281(5):2661-7. doi: 10.1074/jbc.M508485200. Epub 2005 Nov 7.
9
Enhanced metabolic stability and protein-binding properties of artificial alpha helices derived from a hydrogen-bond surrogate: application to Bcl-xL.
Angew Chem Int Ed Engl. 2005 Oct 14;44(40):6525-9. doi: 10.1002/anie.200501603.
10
T cell determinants incorporating beta-amino acid residues are protease resistant and remain immunogenic in vivo.
J Immunol. 2005 Sep 15;175(6):3810-8. doi: 10.4049/jimmunol.175.6.3810.
Zotero 插件